Skip to main content

Table 2 Characteristics of patients diagnosed with occult malignancy

From: “Best practices in risk reducing bilateral salpingo-oophorectomy: the influence of surgical specialty”

Patient Mutation status Age Diagnosis Prognosis
1 Unknown 45 Metastatic breast cancer to ovary (dx at RRBSO 2007) Patient last seen 2011: diagnosis right femoral head metastases 2010 s/p XRT
2 Unknown 54 Leydig cell tumor of the ovary Patient last seen 2012: no evidence of disease
3 Unknown 43 Metastatic breast cancer to ovary (known metastases to lymph nodes) Lost to follow-up
4 Unknown 45 Metastatic breast cancer to ovary (known metastases to bone) 2010: new bone metastases; 2012: extensive bone mets, vertebral body compression fractures; 2017: stable lesions, on denosumab
5 BRCA1+ 44 Papillary serous carcinoma of the fallopian tube s/p 3 cycles carboplatin; no evidence of disease since 2009
6 BRCA+ 44 Papillary serous carcinoma of the fallopian tube s/p 6 cycles carboplatin/Taxol; no evidence of disease since 2009
7 BRCA2+ 68 Papillary serous carcinoma of the fallopian tube s/p carboplatin/Taxol × 3 cycles; no evidence of disease since 2007